Higher risk of primary cancers after polycythaemia vera and vice versa

British Journal of Haematology

Volumn 153, Issue 2, 2011, Pages 283-285

  Fallah, Mahdi ^a   Kharazmi, Elham ^a   Sundquist, Jan ^b,c   Hemminki, Kari ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer epidemiology; Polycythaemia vera; Second cancer

Indexed keywords

ADRENAL TUMOR; CANCER RISK; DISEASE ASSOCIATION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HIGH RISK PATIENT; HUMAN; HYPERPARATHYROIDISM; KIDNEY CANCER; LETTER; LEUKEMIA; MELANOMA; MULTIPLE MYELOMA; MYELOFIBROSIS; PARATHYROID TUMOR; POLYCYTHEMIA VERA; PRIMARY TUMOR; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN CANCER; SWEDEN;

DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; POLYCYTHEMIA VERA; RISK FACTORS; SWEDEN;

EID: 79953095617     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08538.x     Document Type: Letter

References (10)

1. Hayne, S.T., Diestelmier, M.S., Johnson, E.A. & Braund, Jr, R.R. (1985) Polycythemia vera, primary hyperparathyroidism, and dysplastic nevus syndrome: report of a case. American Journal of Clinical Pathology, 83, 512-516.
2. Hemminki, K., Ji, J., Brandt, A., Mousavi, S.M. & Sundquist, J. (2010) The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. International Journal of Cancer, 126, 2259-2267.
3. Landgren, O., Goldin, L.R., Kristinsson, S.Y., Helgadottir, E.A., Samuelsson, J. & Bjorkholm, M. (2008) Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24, 577 first-degree relatives of 11, 039 patients with myeloproliferative neoplasms in Sweden. Blood, 112, 2199-2204.
4. Landolfi, R., Nicolazzi, M.A., Porfidia, A. & Di Gennaro, L. (2010) Polycythemia vera. Internal and Emergency Medicine, 5, 375-384.
5. Najean, Y. (1991) Association of renal carcinoma and polycythemia vera: 5 cases in which nephrectomy preceded and did not influence the clinical course of the polycythemia. Nouvelle Revue Française d'hématologie, 33, 9-10.
6. Pizzolito, S., Barbone, F., Rizzi, C., Scott, A.C., Piemonte, M. & Beltrami, C.A. (1997) Parathyroid adenomas and malignant neoplasms: coincidence or etiological association? Advances in Clinical Pathology, 1, 275-280.
7. Sanchez-Palacios, C. & Guitart, J. (2004) Hydroxyurea-associated squamous dysplasia. Journal of the American Academy of Dermatology, 51, 293-300.
8. Vannucchi, A.M., Guglielmelli, P. & Tefferi, A. (2009a) Advances in understanding and management of myeloproliferative neoplasms. CA: A Cancer Journal for Clinicians, 59, 171-191.
9. Vannucchi, A.M., Masala, G., Antonioli, E., Chiara Susini, M., Guglielmelli, P., Pieri, L., Maggi, L., Caini, S., Palli, D., Bogani, C., Ponziani, V., Pancrazzi, A., Annunziato, F. & Bosi, A. (2009b) Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiology, Biomarkers and Prevention, 18, 2068-2073.
10. Weinstein, R.S. (1991) Parathyroid carcinoma associated with polycythemia vera. Bone, 12, 237-239.